Zobrazeno 1 - 10
of 247
pro vyhledávání: ''
Publikováno v:
Clinical & Experimental Medicine; Feb2023, Vol. 23 Issue 1, p1-16, 16p
Publikováno v:
British Journal of Cancer. 12/7/2009, Vol. 101 Issue 11, p1925-1931. 7p. 2 Charts, 2 Graphs.
Autor:
Talvinen, K.1 kattal@utu.fi, Karra, H.1, Hurme, S.2, Nykänen, M.3, Nieminen, A.3, Anttinen, J.3, Kuopio, T.3, Kronqvist, P.1, Nykänen, M (AUTHOR)
Publikováno v:
British Journal of Cancer. 9/8/2009, Vol. 101 Issue 6, p1005-1010. 6p. 4 Charts, 1 Graph.
Autor:
Stea, B.1 bstea@azcc.arizona.edu, Shaw, E.2, Pintér, T.3, Hackman, J.4, Craig, M.4, May, J.4, Steffen, R. P.4, Suh, J. H.5, Pintér, T (AUTHOR)
Publikováno v:
British Journal of Cancer. 6/19/2006, Vol. 94 Issue 12, p1777-1784. 8p. 7 Charts, 2 Graphs.
Publikováno v:
British Journal of Cancer. 1/17/2005, Vol. 92 Issue 1, p47-54. 8p.
Autor:
Kronqvist, P.1 pauliina.kronqvist@tyks.fi, Kuopio, T.2, Nykänen, M.2, Helenius, H.1, Anttinen, J.2, Klemi, P.1, Nykänen, M (AUTHOR)
Publikováno v:
British Journal of Cancer. 7/19/2004, Vol. 91 Issue 2, p277-281. 5p.
Publikováno v:
npj breast cancer
Breast cancer intrinsic subtypes (IS) are biologically distinct entities, characterized by specific natural gene expression patterns. The most widely accepted IS are the Luminal A, Luminal B, HER2-Enriched, and Basal-like (Fig. 1). These entities are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78db143a8d2117c1a71180bc436ca192
http://hdl.handle.net/2445/194395
http://hdl.handle.net/2445/194395
Autor:
Filipenko, M., Os'kina, N., Oskorbin, I., Mishukova, O., Ovchinnikova, L., Gershtein, E., Kushlinskii, N.
Publikováno v:
Bulletin of Experimental Biology & Medicine; Jun2017, Vol. 163 Issue 2, p250-254, 5p
Autor:
James L. Thorne, Melina C. Teske, Robyn V. Broad, Andrew M. Hanby, Laura M. Wastall, Stacey J. Jones, Thomas A. Hughes
Publikováno v:
British Journal of Cancer
Background Triple negative breast cancers (TNBC) have poor prognoses despite aggressive treatment with cytotoxic chemotherapy. Cancer-associated fibroblasts (CAFs) are prominent in tumour stroma. Our hypothesis was that CAFs modulate chemotherapy sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::027115557c95f3f47f1ecb119dec9f3d
Publikováno v:
Breast Cancer Research Protocols; 2006, p79-89, 11p